This announcement is a separate document:
江苏康缘药业股份有限公司关于上海证券交易所《关于江苏康缘药业股份有限公司关联交易事项的监管工作函》的回复公告
Reply announcement regarding regulatory letter from Shanghai Stock Exchange on related party transactions of Jiangsu Kanion Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.